DAVID A EBERSMAN Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for DAVID A EBERSMAN.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of DAVID A EBERSMAN. DAVID A EBERSMAN is EVP & CHIEF FINANCIAL OFFICER in GENENTECH INC ($DNA) and SENIOR VICE PRESIDENT in GENENTECH INC ($DNA) and SR VP & CFO in GENENTECH INC ($DNA) and Director in CASTLIGHT HEALTH, INC. ($CSLT) and Director in IRONWOOD PHARMACEUTICALS INC ($IRWD) and Director in SVMK Inc. ($SVMK).
Latest Insider Trading Transactions of DAVID A EBERSMAN
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, CSLT, DNA, IRWD, SVMK
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jun 14 2021 | CSLT | CASTLIGHT HEALTH, ... | EBERSMAN DAVID A | Director | Grant | A | 0.00 | 70,707 | 0 | 405,184 | 334.5 K to 405.2 K (+21.14 %) |
Aug 12 2020 | SVMK | SVMK Inc. | EBERSMAN DAVID A | Director | Option Exercise | A | 21.74 | 9,070 | 197,182 | 9,070 | |
Jun 08 2020 | SVMK | SVMK Inc. | EBERSMAN DAVID A | Director | Grant | A | 0.00 | 4,535 | 0 | 44,631 | 40.1 K to 44.6 K (+11.31 %) |
Jun 05 2020 | CSLT | CASTLIGHT HEALTH, ... | EBERSMAN DAVID A | Director | Grant | A | 0.00 | 180,645 | 0 | 334,477 | 153.8 K to 334.5 K (+117.43 %) |
Aug 07 2019 | SVMK | SVMK Inc. | EBERSMAN DAVID A | Director | Option Exercise | A | 18.11 | 10,192 | 184,577 | 10,192 | |
Jun 13 2019 | SVMK | SVMK Inc. | EBERSMAN DAVID A | Director | Grant | A | 0.00 | 5,096 | 0 | 40,096 | 35 K to 40.1 K (+14.56 %) |
Jun 07 2019 | CSLT | CASTLIGHT HEALTH, ... | EBERSMAN DAVID A | Director | Grant | A | 0.00 | 44,164 | 0 | 153,832 | 109.7 K to 153.8 K (+40.27 %) |
Jun 22 2018 | CSLT | CASTLIGHT HEALTH, ... | EBERSMAN DAVID A | Director | Grant | A | 0.00 | 32,183 | 0 | 109,668 | 77.5 K to 109.7 K (+41.53 %) |
Jun 22 2018 | CSLT | CASTLIGHT HEALTH, ... | EBERSMAN DAVID A | Director | Grant | A | 0.00 | 32,183 | 0 | 109,668 | 77.5 K to 109.7 K (+41.53 %) |
Jun 26 2017 | CSLT | CASTLIGHT HEALTH, ... | EBERSMAN DAVID A | Director | Grant | A | 0.00 | 33,735 | 0 | 77,485 | 43.8 K to 77.5 K (+77.11 %) |
Jun 23 2016 | CSLT | CASTLIGHT HEALTH, ... | EBERSMAN DAVID A | Director | Grant | A | 0.00 | 31,250 | 0 | 43,750 | 12.5 K to 43.8 K (+250.00 %) |
Jun 19 2015 | CSLT | CASTLIGHT HEALTH, ... | EBERSMAN DAVID A | Director | Grant | A | 0.00 | 12,500 | 0 | 12,500 | 0 to 12.5 K |
Mar 17 2015 | IRWD | IRONWOOD PHARMACEU ... | EBERSMAN DAVID A | Director | Grant | A | 0.00 | 165 | 0 | 29,714 | 29.5 K to 29.7 K (+0.56 %) |
Mar 30 2009 | DNA | GENENTECH INC | EBERSMAN DAVID A | EVP & CHIEF FINANCI ... | Option Exercise | D | 85.83 | 157,500 | 13,518,225 | 0 | |
Mar 30 2009 | DNA | GENENTECH INC | EBERSMAN DAVID A | EVP & CHIEF FINANCI ... | Option Exercise | D | 79.55 | 125,000 | 9,943,750 | 0 | |
Mar 30 2009 | DNA | GENENTECH INC | EBERSMAN DAVID A | EVP & CHIEF FINANCI ... | Option Exercise | D | 79.17 | 135,000 | 10,687,950 | 0 | |
Mar 30 2009 | DNA | GENENTECH INC | EBERSMAN DAVID A | EVP & CHIEF FINANCI ... | Option Exercise | D | 53.23 | 150,000 | 7,984,500 | 0 | |
Mar 30 2009 | DNA | GENENTECH INC | EBERSMAN DAVID A | EVP & CHIEF FINANCI ... | Option Exercise | D | 42.05 | 132,000 | 5,550,600 | 0 | |
Mar 30 2009 | DNA | GENENTECH INC | EBERSMAN DAVID A | EVP & CHIEF FINANCI ... | Option Exercise | D | 20.90 | 106,400 | 2,223,760 | 0 | |
Mar 30 2009 | DNA | GENENTECH INC | EBERSMAN DAVID A | EVP & CHIEF FINANCI ... | Option Exercise | D | 14.28 | 180,000 | 2,570,400 | 0 | |
Mar 30 2009 | DNA | GENENTECH INC | EBERSMAN DAVID A | EVP & CHIEF FINANCI ... | Sell | D | 95.00 | 4,977 | 472,815 | 0 | 5 K to 0 (-100.00 %) |
Mar 30 2009 | DNA | GENENTECH INC | EBERSMAN DAVID A | EVP & CHIEF FINANCI ... | Sell | D | 95.00 | 3,641 | 345,895 | 0 | 3.6 K to 0 (-100.00 %) |
Jan 20 2009 | DNA | GENENTECH INC | EBERSMAN DAVID A | EVP & CHIEF FINANCI ... | Gift | G | 0.00 | 122 | 0 | 4,977 | 4.9 K to 5 K (+2.51 %) |
Jan 20 2009 | DNA | GENENTECH INC | EBERSMAN DAVID A | EVP & CHIEF FINANCI ... | Gift | G | 0.00 | 122 | 0 | 3,533 | 3.7 K to 3.5 K (-3.34 %) |
Sep 24 2007 | DNA | GENENTECH INC | EBERSMAN DAVID A | EVP & CHIEF FINANCI ... | Option Exercise | A | 79.55 | 125,000 | 9,943,750 | 125,000 | |
Feb 20 2007 | DNA | GENENTECH INC | EBERSMAN DAVID A | EVP & CHIEF FINANCI ... | Option Exercise | M | 20.90 | 900 | 18,810 | 106,400 | |
Feb 20 2007 | DNA | GENENTECH INC | EBERSMAN DAVID A | EVP & CHIEF FINANCI ... | Option Exercise | M | 20.90 | 700 | 14,630 | 107,300 | |
Feb 20 2007 | DNA | GENENTECH INC | EBERSMAN DAVID A | EVP & CHIEF FINANCI ... | Option Exercise | M | 20.90 | 1,200 | 25,080 | 108,000 | |
Feb 20 2007 | DNA | GENENTECH INC | EBERSMAN DAVID A | EVP & CHIEF FINANCI ... | Option Exercise | M | 20.90 | 900 | 18,810 | 109,200 | |
Feb 20 2007 | DNA | GENENTECH INC | EBERSMAN DAVID A | EVP & CHIEF FINANCI ... | Option Exercise | M | 20.90 | 4,500 | 94,050 | 110,100 | |
Feb 20 2007 | DNA | GENENTECH INC | EBERSMAN DAVID A | EVP & CHIEF FINANCI ... | Option Exercise | M | 20.90 | 2,600 | 54,340 | 114,600 | |
Feb 20 2007 | DNA | GENENTECH INC | EBERSMAN DAVID A | EVP & CHIEF FINANCI ... | Option Exercise | M | 20.90 | 4,400 | 91,960 | 117,200 | |
Feb 20 2007 | DNA | GENENTECH INC | EBERSMAN DAVID A | EVP & CHIEF FINANCI ... | Option Exercise | M | 20.90 | 300 | 6,270 | 121,600 | |
Feb 20 2007 | DNA | GENENTECH INC | EBERSMAN DAVID A | EVP & CHIEF FINANCI ... | Option Exercise | M | 20.90 | 1,200 | 25,080 | 121,900 | |
Feb 20 2007 | DNA | GENENTECH INC | EBERSMAN DAVID A | EVP & CHIEF FINANCI ... | Option Exercise | M | 20.90 | 1,500 | 31,350 | 123,100 | |
Feb 20 2007 | DNA | GENENTECH INC | EBERSMAN DAVID A | EVP & CHIEF FINANCI ... | Option Exercise | M | 20.90 | 1,800 | 37,620 | 124,600 | |
Feb 20 2007 | DNA | GENENTECH INC | EBERSMAN DAVID A | EVP & CHIEF FINANCI ... | Option Exercise | M | 20.90 | 1,400 | 29,260 | 126,400 | |
Feb 20 2007 | DNA | GENENTECH INC | EBERSMAN DAVID A | EVP & CHIEF FINANCI ... | Option Exercise | M | 20.90 | 3,400 | 71,060 | 127,800 | |
Feb 20 2007 | DNA | GENENTECH INC | EBERSMAN DAVID A | EVP & CHIEF FINANCI ... | Option Exercise | M | 20.90 | 200 | 4,180 | 131,200 | |
Feb 20 2007 | DNA | GENENTECH INC | EBERSMAN DAVID A | EVP & CHIEF FINANCI ... | Sell | S | 86.76 | 900 | 78,084 | 8,097 | 9 K to 8.1 K (-10.00 %) |
Feb 20 2007 | DNA | GENENTECH INC | EBERSMAN DAVID A | EVP & CHIEF FINANCI ... | Buy | M | 20.90 | 900 | 18,810 | 8,997 | 8.1 K to 9 K (+11.12 %) |
Feb 20 2007 | DNA | GENENTECH INC | EBERSMAN DAVID A | EVP & CHIEF FINANCI ... | Sell | S | 86.78 | 700 | 60,746 | 8,097 | 8.8 K to 8.1 K (-7.96 %) |
Feb 20 2007 | DNA | GENENTECH INC | EBERSMAN DAVID A | EVP & CHIEF FINANCI ... | Buy | M | 20.90 | 700 | 14,630 | 8,797 | 8.1 K to 8.8 K (+8.65 %) |
Feb 20 2007 | DNA | GENENTECH INC | EBERSMAN DAVID A | EVP & CHIEF FINANCI ... | Sell | S | 86.80 | 1,200 | 104,160 | 8,097 | 9.3 K to 8.1 K (-12.91 %) |
Feb 20 2007 | DNA | GENENTECH INC | EBERSMAN DAVID A | EVP & CHIEF FINANCI ... | Buy | M | 20.90 | 1,200 | 25,080 | 9,297 | 8.1 K to 9.3 K (+14.82 %) |
Feb 20 2007 | DNA | GENENTECH INC | EBERSMAN DAVID A | EVP & CHIEF FINANCI ... | Sell | S | 86.82 | 900 | 78,138 | 8,097 | 9 K to 8.1 K (-10.00 %) |
Feb 20 2007 | DNA | GENENTECH INC | EBERSMAN DAVID A | EVP & CHIEF FINANCI ... | Buy | M | 20.90 | 900 | 18,810 | 8,997 | 8.1 K to 9 K (+11.12 %) |
Feb 20 2007 | DNA | GENENTECH INC | EBERSMAN DAVID A | EVP & CHIEF FINANCI ... | Sell | S | 86.85 | 4,500 | 390,825 | 8,097 | 12.6 K to 8.1 K (-35.72 %) |
Feb 20 2007 | DNA | GENENTECH INC | EBERSMAN DAVID A | EVP & CHIEF FINANCI ... | Buy | M | 20.90 | 4,500 | 94,050 | 12,597 | 8.1 K to 12.6 K (+55.58 %) |
Feb 20 2007 | DNA | GENENTECH INC | EBERSMAN DAVID A | EVP & CHIEF FINANCI ... | Sell | S | 86.86 | 2,600 | 225,836 | 8,097 | 10.7 K to 8.1 K (-24.31 %) |
Feb 20 2007 | DNA | GENENTECH INC | EBERSMAN DAVID A | EVP & CHIEF FINANCI ... | Buy | M | 20.90 | 2,600 | 54,340 | 10,697 | 8.1 K to 10.7 K (+32.11 %) |
Feb 20 2007 | DNA | GENENTECH INC | EBERSMAN DAVID A | EVP & CHIEF FINANCI ... | Sell | S | 86.87 | 4,400 | 382,228 | 8,097 | 12.5 K to 8.1 K (-35.21 %) |
Feb 20 2007 | DNA | GENENTECH INC | EBERSMAN DAVID A | EVP & CHIEF FINANCI ... | Buy | M | 20.90 | 4,400 | 91,960 | 12,497 | 8.1 K to 12.5 K (+54.34 %) |
Feb 20 2007 | DNA | GENENTECH INC | EBERSMAN DAVID A | EVP & CHIEF FINANCI ... | Sell | S | 86.88 | 300 | 26,064 | 8,097 | 8.4 K to 8.1 K (-3.57 %) |
Feb 20 2007 | DNA | GENENTECH INC | EBERSMAN DAVID A | EVP & CHIEF FINANCI ... | Buy | M | 20.90 | 300 | 6,270 | 8,397 | 8.1 K to 8.4 K (+3.71 %) |
Feb 20 2007 | DNA | GENENTECH INC | EBERSMAN DAVID A | EVP & CHIEF FINANCI ... | Sell | S | 86.90 | 1,200 | 104,280 | 8,097 | 9.3 K to 8.1 K (-12.91 %) |
Feb 20 2007 | DNA | GENENTECH INC | EBERSMAN DAVID A | EVP & CHIEF FINANCI ... | Buy | M | 20.90 | 1,200 | 25,080 | 9,297 | 8.1 K to 9.3 K (+14.82 %) |
Feb 20 2007 | DNA | GENENTECH INC | EBERSMAN DAVID A | EVP & CHIEF FINANCI ... | Sell | S | 86.91 | 1,500 | 130,365 | 8,097 | 9.6 K to 8.1 K (-15.63 %) |
Feb 20 2007 | DNA | GENENTECH INC | EBERSMAN DAVID A | EVP & CHIEF FINANCI ... | Buy | M | 20.90 | 1,500 | 31,350 | 9,597 | 8.1 K to 9.6 K (+18.53 %) |
Feb 20 2007 | DNA | GENENTECH INC | EBERSMAN DAVID A | EVP & CHIEF FINANCI ... | Sell | S | 86.92 | 1,800 | 156,456 | 8,097 | 9.9 K to 8.1 K (-18.19 %) |
Feb 20 2007 | DNA | GENENTECH INC | EBERSMAN DAVID A | EVP & CHIEF FINANCI ... | Buy | M | 20.90 | 1,800 | 37,620 | 9,897 | 8.1 K to 9.9 K (+22.23 %) |
Feb 20 2007 | DNA | GENENTECH INC | EBERSMAN DAVID A | EVP & CHIEF FINANCI ... | Sell | S | 86.93 | 1,400 | 121,702 | 8,097 | 9.5 K to 8.1 K (-14.74 %) |
Feb 20 2007 | DNA | GENENTECH INC | EBERSMAN DAVID A | EVP & CHIEF FINANCI ... | Buy | M | 20.90 | 1,400 | 29,260 | 9,497 | 8.1 K to 9.5 K (+17.29 %) |
Feb 20 2007 | DNA | GENENTECH INC | EBERSMAN DAVID A | EVP & CHIEF FINANCI ... | Sell | S | 86.94 | 3,400 | 295,596 | 8,097 | 11.5 K to 8.1 K (-29.57 %) |
Feb 20 2007 | DNA | GENENTECH INC | EBERSMAN DAVID A | EVP & CHIEF FINANCI ... | Buy | M | 20.90 | 3,400 | 71,060 | 11,497 | 8.1 K to 11.5 K (+41.99 %) |
Feb 20 2007 | DNA | GENENTECH INC | EBERSMAN DAVID A | EVP & CHIEF FINANCI ... | Sell | S | 86.95 | 200 | 17,390 | 8,097 | 8.3 K to 8.1 K (-2.41 %) |
Feb 20 2007 | DNA | GENENTECH INC | EBERSMAN DAVID A | EVP & CHIEF FINANCI ... | Buy | M | 20.90 | 200 | 4,180 | 8,297 | 8.1 K to 8.3 K (+2.47 %) |
Jan 17 2007 | DNA | GENENTECH INC | EBERSMAN DAVID A | EVP & CHIEF FINANCI ... | Option Exercise | M | 40.99 | 18,132 | 743,231 | 0 | |
Jan 17 2007 | DNA | GENENTECH INC | EBERSMAN DAVID A | EVP & CHIEF FINANCI ... | Option Exercise | M | 40.99 | 7,100 | 291,029 | 18,132 | |
Jan 17 2007 | DNA | GENENTECH INC | EBERSMAN DAVID A | EVP & CHIEF FINANCI ... | Option Exercise | M | 40.99 | 2,100 | 86,079 | 25,232 | |
Jan 17 2007 | DNA | GENENTECH INC | EBERSMAN DAVID A | EVP & CHIEF FINANCI ... | Option Exercise | M | 40.99 | 1,200 | 49,188 | 27,332 | |
Jan 17 2007 | DNA | GENENTECH INC | EBERSMAN DAVID A | EVP & CHIEF FINANCI ... | Option Exercise | M | 40.99 | 800 | 32,792 | 28,532 | |
Jan 17 2007 | DNA | GENENTECH INC | EBERSMAN DAVID A | EVP & CHIEF FINANCI ... | Option Exercise | M | 40.99 | 1,015 | 41,605 | 29,332 | |
Jan 17 2007 | DNA | GENENTECH INC | EBERSMAN DAVID A | EVP & CHIEF FINANCI ... | Option Exercise | M | 40.99 | 500 | 20,495 | 30,347 | |
Jan 17 2007 | DNA | GENENTECH INC | EBERSMAN DAVID A | EVP & CHIEF FINANCI ... | Option Exercise | M | 40.99 | 900 | 36,891 | 30,847 | |
Jan 17 2007 | DNA | GENENTECH INC | EBERSMAN DAVID A | EVP & CHIEF FINANCI ... | Option Exercise | M | 40.99 | 2,100 | 86,079 | 31,747 | |
Jan 17 2007 | DNA | GENENTECH INC | EBERSMAN DAVID A | EVP & CHIEF FINANCI ... | Option Exercise | M | 40.99 | 400 | 16,396 | 33,847 | |
Jan 17 2007 | DNA | GENENTECH INC | EBERSMAN DAVID A | EVP & CHIEF FINANCI ... | Option Exercise | M | 40.99 | 1,600 | 65,584 | 34,247 | |
Jan 17 2007 | DNA | GENENTECH INC | EBERSMAN DAVID A | EVP & CHIEF FINANCI ... | Option Exercise | M | 40.99 | 850 | 34,842 | 35,847 | |
Jan 17 2007 | DNA | GENENTECH INC | EBERSMAN DAVID A | EVP & CHIEF FINANCI ... | Option Exercise | M | 40.99 | 100 | 4,099 | 36,697 | |
Jan 17 2007 | DNA | GENENTECH INC | EBERSMAN DAVID A | EVP & CHIEF FINANCI ... | Option Exercise | M | 40.99 | 1,400 | 57,386 | 36,797 | |
Jan 17 2007 | DNA | GENENTECH INC | EBERSMAN DAVID A | EVP & CHIEF FINANCI ... | Option Exercise | M | 40.99 | 700 | 28,693 | 38,197 | |
Jan 17 2007 | DNA | GENENTECH INC | EBERSMAN DAVID A | EVP & CHIEF FINANCI ... | Option Exercise | M | 40.99 | 100 | 4,099 | 38,897 | |
Jan 17 2007 | DNA | GENENTECH INC | EBERSMAN DAVID A | EVP & CHIEF FINANCI ... | Option Exercise | M | 40.99 | 405 | 16,601 | 38,997 | |
Jan 17 2007 | DNA | GENENTECH INC | EBERSMAN DAVID A | EVP & CHIEF FINANCI ... | Option Exercise | M | 40.99 | 1,000 | 40,990 | 39,402 | |
Jan 17 2007 | DNA | GENENTECH INC | EBERSMAN DAVID A | EVP & CHIEF FINANCI ... | Option Exercise | M | 40.99 | 2,300 | 94,277 | 40,402 | |
Jan 17 2007 | DNA | GENENTECH INC | EBERSMAN DAVID A | EVP & CHIEF FINANCI ... | Option Exercise | M | 40.99 | 205 | 8,403 | 42,702 | |
Jan 17 2007 | DNA | GENENTECH INC | EBERSMAN DAVID A | EVP & CHIEF FINANCI ... | Option Exercise | M | 40.99 | 2,050 | 84,030 | 42,907 | |
Jan 17 2007 | DNA | GENENTECH INC | EBERSMAN DAVID A | EVP & CHIEF FINANCI ... | Option Exercise | M | 40.99 | 550 | 22,545 | 44,957 | |
Jan 17 2007 | DNA | GENENTECH INC | EBERSMAN DAVID A | EVP & CHIEF FINANCI ... | Option Exercise | M | 40.99 | 800 | 32,792 | 45,507 | |
Jan 17 2007 | DNA | GENENTECH INC | EBERSMAN DAVID A | EVP & CHIEF FINANCI ... | Option Exercise | M | 40.99 | 288 | 11,805 | 46,307 | |
Jan 17 2007 | DNA | GENENTECH INC | EBERSMAN DAVID A | EVP & CHIEF FINANCI ... | Option Exercise | M | 40.99 | 700 | 28,693 | 46,595 | |
Jan 17 2007 | DNA | GENENTECH INC | EBERSMAN DAVID A | EVP & CHIEF FINANCI ... | Option Exercise | M | 40.99 | 1,200 | 49,188 | 47,295 | |
Jan 17 2007 | DNA | GENENTECH INC | EBERSMAN DAVID A | EVP & CHIEF FINANCI ... | Option Exercise | M | 40.99 | 600 | 24,594 | 48,495 | |
Jan 17 2007 | DNA | GENENTECH INC | EBERSMAN DAVID A | EVP & CHIEF FINANCI ... | Option Exercise | M | 40.99 | 305 | 12,502 | 49,095 | |
Jan 17 2007 | DNA | GENENTECH INC | EBERSMAN DAVID A | EVP & CHIEF FINANCI ... | Option Exercise | M | 40.99 | 600 | 24,594 | 49,400 | |
Jan 17 2007 | DNA | GENENTECH INC | EBERSMAN DAVID A | EVP & CHIEF FINANCI ... | Sell | S | 87.00 | 18,132 | 1,577,484 | 8,097 | 26.2 K to 8.1 K (-69.13 %) |
Jan 17 2007 | DNA | GENENTECH INC | EBERSMAN DAVID A | EVP & CHIEF FINANCI ... | Buy | M | 40.99 | 18,132 | 743,231 | 26,229 | 8.1 K to 26.2 K (+223.93 %) |
Jan 17 2007 | DNA | GENENTECH INC | EBERSMAN DAVID A | EVP & CHIEF FINANCI ... | Sell | S | 87.01 | 7,100 | 617,771 | 8,097 | 15.2 K to 8.1 K (-46.72 %) |
Jan 17 2007 | DNA | GENENTECH INC | EBERSMAN DAVID A | EVP & CHIEF FINANCI ... | Buy | M | 40.99 | 7,100 | 291,029 | 15,197 | 8.1 K to 15.2 K (+87.69 %) |
Jan 17 2007 | DNA | GENENTECH INC | EBERSMAN DAVID A | EVP & CHIEF FINANCI ... | Sell | S | 87.02 | 2,100 | 182,742 | 8,097 | 10.2 K to 8.1 K (-20.59 %) |
Jan 17 2007 | DNA | GENENTECH INC | EBERSMAN DAVID A | EVP & CHIEF FINANCI ... | Buy | M | 40.99 | 2,100 | 86,079 | 10,197 | 8.1 K to 10.2 K (+25.94 %) |
Jan 17 2007 | DNA | GENENTECH INC | EBERSMAN DAVID A | EVP & CHIEF FINANCI ... | Sell | S | 87.03 | 1,200 | 104,436 | 8,097 | 9.3 K to 8.1 K (-12.91 %) |
Jan 17 2007 | DNA | GENENTECH INC | EBERSMAN DAVID A | EVP & CHIEF FINANCI ... | Buy | M | 40.99 | 1,200 | 49,188 | 9,297 | 8.1 K to 9.3 K (+14.82 %) |
Jan 17 2007 | DNA | GENENTECH INC | EBERSMAN DAVID A | EVP & CHIEF FINANCI ... | Sell | S | 87.04 | 800 | 69,632 | 8,097 | 8.9 K to 8.1 K (-8.99 %) |
Jan 17 2007 | DNA | GENENTECH INC | EBERSMAN DAVID A | EVP & CHIEF FINANCI ... | Buy | M | 40.99 | 800 | 32,792 | 8,897 | 8.1 K to 8.9 K (+9.88 %) |
Jan 17 2007 | DNA | GENENTECH INC | EBERSMAN DAVID A | EVP & CHIEF FINANCI ... | Sell | S | 87.05 | 1,015 | 88,356 | 8,097 | 9.1 K to 8.1 K (-11.14 %) |
Jan 17 2007 | DNA | GENENTECH INC | EBERSMAN DAVID A | EVP & CHIEF FINANCI ... | Buy | M | 40.99 | 1,015 | 41,605 | 9,112 | 8.1 K to 9.1 K (+12.54 %) |
Jan 17 2007 | DNA | GENENTECH INC | EBERSMAN DAVID A | EVP & CHIEF FINANCI ... | Sell | S | 87.06 | 500 | 43,530 | 8,097 | 8.6 K to 8.1 K (-5.82 %) |
Jan 17 2007 | DNA | GENENTECH INC | EBERSMAN DAVID A | EVP & CHIEF FINANCI ... | Buy | M | 40.99 | 500 | 20,495 | 8,597 | 8.1 K to 8.6 K (+6.18 %) |
Jan 17 2007 | DNA | GENENTECH INC | EBERSMAN DAVID A | EVP & CHIEF FINANCI ... | Sell | S | 87.07 | 900 | 78,363 | 8,097 | 9 K to 8.1 K (-10.00 %) |
Jan 17 2007 | DNA | GENENTECH INC | EBERSMAN DAVID A | EVP & CHIEF FINANCI ... | Buy | M | 40.99 | 900 | 36,891 | 8,997 | 8.1 K to 9 K (+11.12 %) |
Jan 17 2007 | DNA | GENENTECH INC | EBERSMAN DAVID A | EVP & CHIEF FINANCI ... | Sell | S | 87.08 | 2,100 | 182,868 | 8,097 | 10.2 K to 8.1 K (-20.59 %) |
Jan 17 2007 | DNA | GENENTECH INC | EBERSMAN DAVID A | EVP & CHIEF FINANCI ... | Buy | M | 40.99 | 2,100 | 86,079 | 10,197 | 8.1 K to 10.2 K (+25.94 %) |
Jan 17 2007 | DNA | GENENTECH INC | EBERSMAN DAVID A | EVP & CHIEF FINANCI ... | Sell | S | 87.09 | 400 | 34,836 | 8,097 | 8.5 K to 8.1 K (-4.71 %) |
Jan 17 2007 | DNA | GENENTECH INC | EBERSMAN DAVID A | EVP & CHIEF FINANCI ... | Buy | M | 40.99 | 400 | 16,396 | 8,497 | 8.1 K to 8.5 K (+4.94 %) |
Jan 17 2007 | DNA | GENENTECH INC | EBERSMAN DAVID A | EVP & CHIEF FINANCI ... | Sell | S | 87.10 | 1,600 | 139,360 | 8,097 | 9.7 K to 8.1 K (-16.50 %) |
Jan 17 2007 | DNA | GENENTECH INC | EBERSMAN DAVID A | EVP & CHIEF FINANCI ... | Buy | M | 40.99 | 1,600 | 65,584 | 9,697 | 8.1 K to 9.7 K (+19.76 %) |
Jan 17 2007 | DNA | GENENTECH INC | EBERSMAN DAVID A | EVP & CHIEF FINANCI ... | Sell | S | 87.11 | 850 | 74,044 | 8,097 | 8.9 K to 8.1 K (-9.50 %) |
Jan 17 2007 | DNA | GENENTECH INC | EBERSMAN DAVID A | EVP & CHIEF FINANCI ... | Buy | M | 40.99 | 850 | 34,842 | 8,947 | 8.1 K to 8.9 K (+10.50 %) |
Jan 17 2007 | DNA | GENENTECH INC | EBERSMAN DAVID A | EVP & CHIEF FINANCI ... | Sell | S | 87.12 | 100 | 8,712 | 8,097 | 8.2 K to 8.1 K (-1.22 %) |
Jan 17 2007 | DNA | GENENTECH INC | EBERSMAN DAVID A | EVP & CHIEF FINANCI ... | Buy | M | 40.99 | 100 | 4,099 | 8,197 | 8.1 K to 8.2 K (+1.24 %) |
Jan 17 2007 | DNA | GENENTECH INC | EBERSMAN DAVID A | EVP & CHIEF FINANCI ... | Sell | S | 87.13 | 1,400 | 121,982 | 8,097 | 9.5 K to 8.1 K (-14.74 %) |
Jan 17 2007 | DNA | GENENTECH INC | EBERSMAN DAVID A | EVP & CHIEF FINANCI ... | Buy | M | 40.99 | 1,400 | 57,386 | 9,497 | 8.1 K to 9.5 K (+17.29 %) |
Jan 17 2007 | DNA | GENENTECH INC | EBERSMAN DAVID A | EVP & CHIEF FINANCI ... | Sell | S | 87.14 | 700 | 60,998 | 8,097 | 8.8 K to 8.1 K (-7.96 %) |
Jan 17 2007 | DNA | GENENTECH INC | EBERSMAN DAVID A | EVP & CHIEF FINANCI ... | Buy | M | 40.99 | 700 | 28,693 | 8,797 | 8.1 K to 8.8 K (+8.65 %) |
Jan 17 2007 | DNA | GENENTECH INC | EBERSMAN DAVID A | EVP & CHIEF FINANCI ... | Sell | S | 87.15 | 100 | 8,715 | 8,097 | 8.2 K to 8.1 K (-1.22 %) |
Jan 17 2007 | DNA | GENENTECH INC | EBERSMAN DAVID A | EVP & CHIEF FINANCI ... | Buy | M | 40.99 | 100 | 4,099 | 8,197 | 8.1 K to 8.2 K (+1.24 %) |
Jan 17 2007 | DNA | GENENTECH INC | EBERSMAN DAVID A | EVP & CHIEF FINANCI ... | Sell | S | 87.16 | 405 | 35,300 | 8,097 | 8.5 K to 8.1 K (-4.76 %) |
Jan 17 2007 | DNA | GENENTECH INC | EBERSMAN DAVID A | EVP & CHIEF FINANCI ... | Buy | M | 40.99 | 405 | 16,601 | 8,502 | 8.1 K to 8.5 K (+5.00 %) |
Jan 17 2007 | DNA | GENENTECH INC | EBERSMAN DAVID A | EVP & CHIEF FINANCI ... | Sell | S | 87.17 | 1,000 | 87,170 | 8,097 | 9.1 K to 8.1 K (-10.99 %) |
Jan 17 2007 | DNA | GENENTECH INC | EBERSMAN DAVID A | EVP & CHIEF FINANCI ... | Buy | M | 40.99 | 1,000 | 40,990 | 9,097 | 8.1 K to 9.1 K (+12.35 %) |
Jan 17 2007 | DNA | GENENTECH INC | EBERSMAN DAVID A | EVP & CHIEF FINANCI ... | Sell | S | 87.18 | 2,300 | 200,514 | 8,097 | 10.4 K to 8.1 K (-22.12 %) |
Jan 17 2007 | DNA | GENENTECH INC | EBERSMAN DAVID A | EVP & CHIEF FINANCI ... | Buy | M | 40.99 | 2,300 | 94,277 | 10,397 | 8.1 K to 10.4 K (+28.41 %) |
Jan 17 2007 | DNA | GENENTECH INC | EBERSMAN DAVID A | EVP & CHIEF FINANCI ... | Sell | S | 87.19 | 205 | 17,874 | 8,097 | 8.3 K to 8.1 K (-2.47 %) |
Jan 17 2007 | DNA | GENENTECH INC | EBERSMAN DAVID A | EVP & CHIEF FINANCI ... | Buy | M | 40.99 | 205 | 8,403 | 8,302 | 8.1 K to 8.3 K (+2.53 %) |
Jan 17 2007 | DNA | GENENTECH INC | EBERSMAN DAVID A | EVP & CHIEF FINANCI ... | Sell | S | 87.20 | 2,050 | 178,760 | 8,097 | 10.1 K to 8.1 K (-20.20 %) |
Jan 17 2007 | DNA | GENENTECH INC | EBERSMAN DAVID A | EVP & CHIEF FINANCI ... | Buy | M | 40.99 | 2,050 | 84,030 | 10,147 | 8.1 K to 10.1 K (+25.32 %) |
Jan 17 2007 | DNA | GENENTECH INC | EBERSMAN DAVID A | EVP & CHIEF FINANCI ... | Sell | S | 87.22 | 550 | 47,971 | 8,097 | 8.6 K to 8.1 K (-6.36 %) |
Jan 17 2007 | DNA | GENENTECH INC | EBERSMAN DAVID A | EVP & CHIEF FINANCI ... | Buy | M | 40.99 | 550 | 22,545 | 8,647 | 8.1 K to 8.6 K (+6.79 %) |
Jan 17 2007 | DNA | GENENTECH INC | EBERSMAN DAVID A | EVP & CHIEF FINANCI ... | Sell | S | 87.23 | 800 | 69,784 | 8,097 | 8.9 K to 8.1 K (-8.99 %) |
Jan 17 2007 | DNA | GENENTECH INC | EBERSMAN DAVID A | EVP & CHIEF FINANCI ... | Buy | M | 40.99 | 800 | 32,792 | 8,897 | 8.1 K to 8.9 K (+9.88 %) |
Jan 17 2007 | DNA | GENENTECH INC | EBERSMAN DAVID A | EVP & CHIEF FINANCI ... | Sell | S | 87.24 | 288 | 25,125 | 8,097 | 8.4 K to 8.1 K (-3.43 %) |
Jan 17 2007 | DNA | GENENTECH INC | EBERSMAN DAVID A | EVP & CHIEF FINANCI ... | Buy | M | 40.99 | 288 | 11,805 | 8,385 | 8.1 K to 8.4 K (+3.56 %) |
Jan 17 2007 | DNA | GENENTECH INC | EBERSMAN DAVID A | EVP & CHIEF FINANCI ... | Sell | S | 87.25 | 700 | 61,075 | 8,097 | 8.8 K to 8.1 K (-7.96 %) |
Jan 17 2007 | DNA | GENENTECH INC | EBERSMAN DAVID A | EVP & CHIEF FINANCI ... | Buy | M | 40.99 | 700 | 28,693 | 8,797 | 8.1 K to 8.8 K (+8.65 %) |
Jan 17 2007 | DNA | GENENTECH INC | EBERSMAN DAVID A | EVP & CHIEF FINANCI ... | Sell | S | 87.27 | 1,200 | 104,724 | 8,097 | 9.3 K to 8.1 K (-12.91 %) |
Jan 17 2007 | DNA | GENENTECH INC | EBERSMAN DAVID A | EVP & CHIEF FINANCI ... | Buy | M | 40.99 | 1,200 | 49,188 | 9,297 | 8.1 K to 9.3 K (+14.82 %) |
Jan 17 2007 | DNA | GENENTECH INC | EBERSMAN DAVID A | EVP & CHIEF FINANCI ... | Sell | S | 87.28 | 600 | 52,368 | 8,097 | 8.7 K to 8.1 K (-6.90 %) |
Jan 17 2007 | DNA | GENENTECH INC | EBERSMAN DAVID A | EVP & CHIEF FINANCI ... | Buy | M | 40.99 | 600 | 24,594 | 8,697 | 8.1 K to 8.7 K (+7.41 %) |